Lord, Abbett & Co’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $218K | Buy |
3,029
+17
| +0.6% | +$1.31K | ﹤0.01% | 554 |
|
|
2025
Q4 | $239K | Buy |
3,012
+344
| +13% | +$27.1K | ﹤0.01% | 540 |
|
|
2025
Q3 | $201K | Sell |
2,668
-346
| -11% | -$23.7K | ﹤0.01% | 528 |
|
|
2025
Q2 | $208K | Buy |
+3,014
| New | +$198K | ﹤0.01% | 509 |
|
|
2023
Q3 | – | Sell |
-26,243
| Closed | -$1.81M | – | 540 |
|
|
2023
Q2 | $1.81M | Sell |
26,243
-426,860
| -94% | -$30.4M | 0.01% | 522 |
|
|
2023
Q1 | $33.7M | Sell |
453,103
-528
| -0.1% | -$44.3K | 0.12% | 248 |
|
|
2022
Q4 | $42.3M | Sell |
453,631
-102,578
| -18% | -$9.9M | 0.15% | 202 |
|
|
2022
Q3 | $53M | Sell |
556,209
-142,696
| -20% | -$14.1M | 0.19% | 144 |
|
|
2022
Q2 | $64.8M | Buy |
698,905
+403,351
| +136% | +$39.4M | 0.23% | 120 |
|
|
2022
Q1 | $29.9M | Buy |
295,554
+53,430
| +22% | +$5.61M | 0.08% | 309 |
|
|
2021
Q4 | $25M | Sell |
242,124
-396,645
| -62% | -$36.7M | 0.06% | 364 |
|
|
2021
Q3 | $54.2M | Sell |
638,769
-301,079
| -32% | -$25.2M | 0.13% | 245 |
|
|
2021
Q2 | $78.4M | Sell |
939,848
-35,395
| -4% | -$2.9M | 0.19% | 160 |
|
|
2021
Q1 | $73.4M | Sell |
975,243
-37,295
| -4% | -$2.72M | 0.19% | 176 |
|
|
2020
Q4 | $69.2M | Sell |
1,012,538
-1,007,492
| -50% | -$65.5M | 0.18% | 177 |
|
|
2020
Q3 | $118M | Sell |
2,020,030
-440,364
| -18% | -$27.4M | 0.38% | 69 |
|
|
2020
Q2 | $160M | Buy |
2,460,394
+8,487
| +0.3% | +$534K | 0.56% | 26 |
|
|
2020
Q1 | $145M | Buy |
2,451,907
+83,350
| +4% | +$5.56M | 0.64% | 21 |
|
|
2019
Q4 | $176M | Buy |
2,368,557
+681,940
| +40% | +$47.9M | 0.59% | 19 |
|
|
2019
Q3 | $106M | Buy |
1,686,617
+180,210
| +12% | +$10.7M | 0.36% | 63 |
|
|
2019
Q2 | $82.1M | Buy |
1,506,407
+748,261
| +99% | +$40.3M | 0.27% | 107 |
|
|
2019
Q1 | $40.9M | Sell |
758,146
-607,575
| -44% | -$37.5M | 0.14% | 244 |
|
|
2018
Q4 | $89.5M | Buy |
1,365,721
+301,636
| +28% | +$22.5M | 0.33% | 65 |
|
|
2018
Q3 | $83.8M | Sell |
1,064,085
-15,615
| -1% | -$1.12M | 0.23% | 117 |
|
|
2018
Q2 | $69.5M | Buy |
1,079,700
+187,500
| +21% | +$12.4M | 0.2% | 152 |
|
|
2018
Q1 | $55.5M | Sell |
892,200
-665,708
| -43% | -$47.8M | 0.16% | 188 |
|
|
2017
Q4 | $113M | Buy |
1,557,908
+50,964
| +3% | +$3.71M | 0.32% | 65 |
|
|
2017
Q3 | $123M | Buy |
1,506,944
+856,730
| +132% | +$67.8M | 0.36% | 51 |
|
|
2017
Q2 | $52.3M | Sell |
650,214
-230,947
| -26% | -$18.2M | 0.16% | 201 |
|
|
2017
Q1 | $69.2M | Buy |
881,161
+215,930
| +32% | +$17.2M | 0.21% | 141 |
|
|
2016
Q4 | $52.5M | Sell |
665,231
-459,104
| -41% | -$37.1M | 0.16% | 195 |
|
|
2016
Q3 | $100M | Sell |
1,124,335
-24,709
| -2% | -$2.33M | 0.31% | 79 |
|
|
2016
Q2 | $110M | Sell |
1,149,044
-314,618
| -21% | -$31.4M | 0.34% | 58 |
|
|
2016
Q1 | $152M | Buy |
1,463,662
+606,547
| +71% | +$59M | 0.48% | 29 |
|
|
2015
Q4 | $83.8M | Sell |
857,115
-85,263
| -9% | -$8.35M | 0.25% | 95 |
|
|
2015
Q3 | $90.9M | Buy |
942,378
+107,356
| +13% | +$11.3M | 0.27% | 89 |
|
|
2015
Q2 | $87.6M | Sell |
835,022
-49,490
| -6% | -$5.06M | 0.23% | 111 |
|
|
2015
Q1 | $91.3M | Buy |
884,512
+146,010
| +20% | +$14.8M | 0.23% | 105 |
|
|
2014
Q4 | $71.1M | Buy |
738,502
+343,154
| +87% | +$30.2M | 0.18% | 147 |
|
|
2014
Q3 | $31.5M | Buy |
395,348
+118,254
| +43% | +$9.32M | 0.08% | 356 |
|
|
2014
Q2 | $20.9M | Sell |
277,094
-62,220
| -18% | -$4.7M | 0.05% | 517 |
|
|
2014
Q1 | $25.4M | Sell |
339,314
-139,663
| -29% | -$9.87M | 0.06% | 451 |
|
|
2013
Q4 | $34.3M | Buy |
478,977
+69,832
| +17% | +$4.49M | 0.08% | 380 |
|
|
2013
Q3 | $23.2M | Sell |
409,145
-1,848,936
| -82% | -$110M | 0.05% | 481 |
|
|
2013
Q2 | $129M | Buy |
+2,258,081
| New | +$131M | 0.3% | 77 |
|
Other funds holding CVS
VCM
VPM
Lord, Abbett & Co's CVS Position: Q1 2026 in Review
Lord, Abbett & Co increased its CVS Health (CVS) stake by 0.56% in Q1 2026, buying an estimated $1.31K and bringing the position to 3,029 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #554.
Lord, Abbett & Co first reported a position in CVS in Q2 2013 and has held it in 45 quarters since. The position peaked at $176M in Q4 2019. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Lord, Abbett & Co held 3,029 shares of CVS Health worth $218K as of Q1 2026.
- Lord, Abbett & Co bought 17 CVS Health shares in Q1 2026, an estimated $1.31K.
- CVS Health made up ﹤0.01% of Lord, Abbett & Co's portfolio in Q1 2026, its #554 holding.
- Lord, Abbett & Co first reported a position in CVS Health in Q2 2013 and has held it in 45 quarters since.
- Lord, Abbett & Co's CVS Health position peaked at $176M in Q4 2019.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Lord, Abbett & Co's 13F filing for Q1 2026, filed 14 May 2026.